Literature DB >> 21914426

Cancer Care Ontario Guidelines for radical prostatectomy: striving for continuous quality improvement in community practice.

Todd M Webster1, Christopher Newell, John F Amrhein, Ken J Newell.   

Abstract

OBJECTIVE: : Cancer Care Ontario has published an evidence-based guideline on their website "Guideline for Optimization of Surgical and Pathological Quality Performance for Radical Prostatectomy in Prostate Cancer Management: Surgical and Pathological Guidelines." The evidentiary base for this guideline was recently published in CUAJ. The CCO guideline proposes the following: a positive surgical margin (PSM) rate of <25% for organ-confined disease (pT2), a perioperative mortality of <1%, a rate of rectal injury <1%, and a blood transfusion rate <10% in non-anemic patients. The objective of this study was to review the radical prostatectomy practice at the Grey Bruce Health Services, an Ontario community hospital, and to compare our performance in relation to the Cancer Care Ontario guideline and the literature.
METHODS: : We conducted a retrospective review of all radical prostatectomies performed at the Grey Bruce Health Services from January 1, 2006 to December 31, 2007. The following data were obtained from clinical records and pathology reports: patient age, pre-biopsy prostate-specific antigen, biopsy Gleason score, resected prostate gland weight, radical prostatectomy Gleason score, surgical margin status, pathological tumour stage (pT), lymph node dissection status, perioperative incidence of transfusion of blood products and if the patient was anemic (hemoglobin <140 g/L) preoperatively, incidence of rectal injury, and perioperative mortality within 30 days following surgery.
RESULTS: : Using the method proposed by D'Amico, most patients undergoing radical prostatectomy were intermediate risk (62%), with a minority of low-risk (24%) and high-risk (14%) patients. The overall PSM rate was 37%. The rate of PSMs in organ-confined disease (pT2) was 26%. There was a statistically significant trend between increasing D'Amico risk category and increasing rate of PSM (Cochran-Armitage trend test, p = 0.023). There was a strong correlation between the pathological tumour stage and the rate of PSM (Cochran-Armitage trend test, p = 0.0003). The rate of blood transfusion in non-anemic patients was 6%. There was 1 patient (0.8%) who experienced a rectal injury. There were no perioperative deaths in our study group.
CONCLUSION: : Our results show that a community hospital group can appropriately select patients to undergo radical prostatectomy, as well as achieve an acceptable rate of PSMs. We believe that ongoing critical appraisal and reflective practice are essential to improving surgical outcomes and providing quality care.

Entities:  

Year:  2012        PMID: 21914426      PMCID: PMC3526627          DOI: 10.5489/cuaj.10195

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  13 in total

Review 1.  Pathologic assessment of the surgical specimen.

Authors:  J I Epstein
Journal:  Urol Clin North Am       Date:  2001-08       Impact factor: 2.241

Review 2.  Impact of positive surgical margins after radical prostatectomy.

Authors:  Sam S Chang; Michael S Cookson
Journal:  Urology       Date:  2006-08       Impact factor: 2.649

3.  Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.

Authors:  Andrew J Evans; Pauline C Henry; Theodorus H Van der Kwast; Douglas C Tkachuk; Kemp Watson; Gina A Lockwood; Neil E Fleshner; Carol Cheung; Eric C Belanger; Mahul B Amin; Liliane Boccon-Gibod; David G Bostwick; Lars Egevad; Jonathan I Epstein; David J Grignon; Edward C Jones; Rodolfo Montironi; Madeleine Moussa; Joan M Sweet; Kiril Trpkov; Thomas M Wheeler; John R Srigley
Journal:  Am J Surg Pathol       Date:  2008-10       Impact factor: 6.394

Review 4.  Surgical modifications of radical retropubic prostatectomy to decrease incidence of positive surgical margins.

Authors:  N F Alsikafi; C B Brendler
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

Review 5.  Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Authors:  M Han; A W Partin; C R Pound; J I Epstein; P C Walsh
Journal:  Urol Clin North Am       Date:  2001-08       Impact factor: 2.241

6.  Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins.

Authors:  Michael A Simon; Sandy Kim; Mark S Soloway
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

7.  Impact of surgical margin status on long-term cancer control after radical prostatectomy.

Authors:  Marcelo A Orvieto; Nejd F Alsikafi; Arieh L Shalhav; Brett A Laven; Gary D Steinberg; Gregory P Zagaja; Charles B Brendler
Journal:  BJU Int       Date:  2006-12       Impact factor: 5.588

8.  Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.

Authors:  James A Eastham; Michael W Kattan; Elyn Riedel; Colin B Begg; Thomas M Wheeler; Claudia Gerigk; Mithat Gonen; Victor Reuter; Peter T Scardino
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

Review 9.  Minor modifications in apical dissection of radical retropubic prostatectomy in patients with clinical stage T2 prostate cancer reduce positive surgical margin incidence.

Authors:  Brett A Laven; Nejd F Alsikafi; Ximing J Yang; Charles B Brendler
Journal:  Urology       Date:  2004-01       Impact factor: 2.649

Review 10.  Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.

Authors:  J A Wieder; M S Soloway
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450

View more
  5 in total

Review 1.  Utilization of Prostate Cancer Quality Metrics for Research and Quality Improvement: A Structured Review.

Authors:  Davide Gori; Rajendra Dulal; Douglas W Blayney; James D Brooks; Maria P Fantini; Kathryn M McDonald; Tina Hernandez-Boussard
Journal:  Jt Comm J Qual Patient Saf       Date:  2018-09-18

2.  Revving up our service to Canadian Urology: CUAJ a proud venue.

Authors:  D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

3.  Intensification de nos services à l'urologie canadienne : le JAUC, un périodique fier.

Authors:  D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

4.  Guidelines and quality outcomes in cancer surgery: Goals, expectations and reality television.

Authors:  Stephen E Pautler
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

5.  Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology.

Authors:  Arielle Elkrief; Petr Kavan; Thierry Alcindor; Genevieve Redstone; Luca Petruccelli; Alla'a Ali; Doneal Thomas; Myriam Fernandez; Caroline Rousseau; Olga Aleynikova; Dawn Anderson; Gabriela Ghitulescu; Carol-Ann Vasilevsky; Richard Dalfen; Adrian Langleben; Sender Liberman
Journal:  BMJ Open Qual       Date:  2021-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.